SureTrader
Interactive Brokers Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 10/21/2017 5:53:59 PM - Followers: 1355 - Board type: Free - Posts Today: 0

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

SureTrader
Interactive Brokers Advertisement
PostSubject
#214481  Sticky Note Risk of Death Persists for Years after Hip Fracture Titan V 10/21/17 12:44:19 PM
#214478  Sticky Note From PR: However, the primary endpoint, which evaluates iwfal 10/20/17 09:20:13 PM
#214475  Sticky Note AGEN—+17%/AH—on FDA approval of GSK’s Shingrix shingles vaccine, DewDiligence 10/20/17 08:24:37 PM
#214469  Sticky Note ABEO: At the R&D Day the MPS presenter said ghmm 10/20/17 03:16:49 PM
#214359  Sticky Note IMDX -19%—my take from today’s CC… DewDiligence 10/17/17 03:19:07 PM
#213801  Sticky Note Re: Buying in advance of phase-3 DewDiligence 09/23/17 02:15:40 PM
#214482   Liquidation fund distribution, an example (off topic) dangerM 10/21/17 05:53:58 PM
#214481   Risk of Death Persists for Years after Hip Fracture Titan V 10/21/17 12:44:19 PM
#214480   DBVT Even if ultimately approved, how much has iwfal 10/21/17 11:54:20 AM
#214479   DBVT - All told I think it would mcbio 10/21/17 10:22:43 AM
#214478   From PR: However, the primary endpoint, which evaluates iwfal 10/20/17 09:20:13 PM
#214477   FWIW, I add more today and already have kris_kade 10/20/17 09:12:19 PM
#214476   ATRS receives CRL for Xyosted: DewDiligence 10/20/17 08:54:11 PM
#214475   AGEN—+17%/AH—on FDA approval of GSK’s Shingrix shingles vaccine, DewDiligence 10/20/17 08:24:37 PM
#214474   trxc - CEO exercised 0.35 options sells 600K nowlurking 10/20/17 07:28:00 PM
#214473   From same DBVT—(-60%/AH)—PR: DBV Technologies…today announced topline results DewDiligence 10/20/17 04:59:34 PM
#214472   DBVT fails https://media.dbv-technologies.com/d286/ressources/_pdf/5/4257-PR-PEP ronpopeil 10/20/17 04:57:21 PM
#214471   hey i am adding lol, not kidding either. linhdtu 10/20/17 03:56:47 PM
#214470   GILD and ABBV lobbying for stupidity? Just kidding rkrw 10/20/17 03:36:11 PM
#214469   ABEO: At the R&D Day the MPS presenter said ghmm 10/20/17 03:16:49 PM
#214468   RVNC has always been a volatile stock. I DewDiligence 10/20/17 02:56:12 PM
#214467   RVNC down $.40~$.50 per day rather consistently over biotech_researcher 10/20/17 02:46:54 PM
#214466   Re: CELG ciotera 10/20/17 01:45:23 PM
#214465   “CVS is going to be under considerable pressure biotech_researcher 10/20/17 01:34:35 PM
#214464   CXRX -33% on plan to "realign...capital structure": DewDiligence 10/20/17 01:34:31 PM
#214463   ABEO ...PPS rises following $92 m offering Whalatane 10/20/17 12:43:08 PM
#214462   >$10B NPV? DewDiligence 10/20/17 12:04:01 PM
#214461   Re: CELG ciotera 10/20/17 12:02:45 PM
#214460   DRRX -60% on phase-3 failure of Posimir in DewDiligence 10/20/17 11:36:40 AM
#214459   CELG -10%—(>$10B market-cap reduction)—on GED-0301 termination. Evidently, some DewDiligence 10/20/17 11:27:37 AM
#214458   ENTA—Mavyret scripts for week ending 10/13/17 (according to DewDiligence 10/20/17 10:34:37 AM
#214457   RXDX sells 11.5M* shares @$16.00—a 1.5% discount to DewDiligence 10/19/17 08:42:15 PM
#214456   Oh ok thanks. So adhd will be about camacho 10/19/17 08:33:16 PM
#214455   ADHD’s share count will increase by 150% when DewDiligence 10/19/17 08:24:41 PM
#214454   Dew, does the reverse merger increase the current camacho 10/19/17 08:06:47 PM
#214453   Yes it does. On balance there isn't n4807g 10/19/17 07:56:54 PM
#214452   Recent Biotech Buyouts of Publicly Traded Companies DewDiligence 10/19/17 07:06:31 PM
#214451   IMDZ ...yep ...don't mess with Dew ...:-) . Whalatane 10/19/17 06:47:57 PM
#214450   It's unlikely that AGN would split in such DewDiligence 10/19/17 06:35:56 PM
#214449   (RVNC) - Allergan's stock-price struggles sure to trigger Bickema 10/19/17 06:25:03 PM
#214448   RE ADHD yes but it does make a mazlat10 10/19/17 06:13:20 PM
#214447   Thanks much re ADHD mazlat10 10/19/17 06:10:45 PM
#214446   IMDZ -50% on the week (eom). DewDiligence 10/19/17 05:21:35 PM
#214445   Oops! DewDiligence 10/19/17 05:16:08 PM
#214444   Good news for CELG: They won't have to DewDiligence 10/19/17 05:14:30 PM
#214443   CELG discontinues GED-0301 (mongersen) IBD program following futility DewDiligence 10/19/17 04:48:08 PM
#214442   Re: UV/blue-light emissions from consumer devices DewDiligence 10/19/17 03:20:00 PM
#214441   Is that important? n4807g 10/19/17 02:27:58 PM
#214440   Arcturus is still private (until the reverse-merger with DewDiligence 10/19/17 02:15:16 PM
#214439   RE ADHD Why no mention of how much mazlat10 10/19/17 02:07:37 PM
#214438   TYME (f/k/a TYMI) data dredging lifts stock 6%: DewDiligence 10/19/17 01:46:29 PM
#214437   CNCE +10% on denial of INCY’s IPR petition DewDiligence 10/19/17 01:41:51 PM
#214436   GLMD “NASH KOL” webcast 10/26/17: DewDiligence 10/19/17 01:37:15 PM
#214435   liking his "definitely" ash111 10/19/17 01:10:20 PM
#214434   CVS is going to be under considerable pressure willyw 10/19/17 01:09:11 PM
#214433   ONCS +13%, Adam F. "Right now, updated data ash111 10/19/17 01:06:40 PM
PostSubject